Novo Nordisk Shares Are 70% Off Their Peak. Is the Stock Fairly Valued?
Demand for the Danish pharmaceutical giant’s Wegovy pill fell shy of expectations in second quarter results.
Morningstar Europe
Company Earnings
Orsted: What We Think of the Stock After Earnings
Maersk: What We Think of the Stock After Earnings
After Earnings, Is Palantir a Buy, a Sell, or Fairly Valued?
After Earnings, Is Amazon Stock a Buy, a Sell, or Fairly Valued?
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
After Earnings, Is Apple Stock a Buy, a Sell, or Fairly Valued?
Novo Nordisk: What We Think of the Stock After Earnings
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
SpaceX: What We Think of the Stock After Earnings
HSBC: What We Think of the Stock After Earnings
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
Palantir: What We Think of the Stock After Earnings
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
Ahead of Earnings, Is Siemens Energy Stock a Buy, a Sell, or Fairly Valued?
Going Into Earnings, Is Siemens Stock a Buy, a Sell, or Fairly Valued?
Stocks
Funds
Market Insights
Videos
Rolls-Royce Share Price Hits Record High: Is the FTSE 100 Stock Still a Buy?
LVMH, Prada, and Kering: Top Stock Picks in Luxury
Vanguard’s Gemmell: How Bond Investors Can Navigate a Volatile Rate Environment
AI Risks and Resilient Stocks: Morningstar’s EMEA CIO on the Global Market Outlook
LVMH Shares Are Down 50% Off Their Peak. Is a Rebound Coming?
Where the US Stock Market May Be Heading Next and What to Buy Now
Stellantis Share Price Is Down 80%. Can Q2 Earnings Trigger a Recovery?
This AI Stock is Up 75% in 2026. Is the European Chipmaker a Buy Now?
What Investors Should Watch for in the Second Half of 2026
Dividend Investing: How to Find the Right Balance Between Income and Growth
